Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 15,294 shares (grant or award)
  2. 4 Grant or award Director acquired 15,294 shares (grant or award)
  3. 4 Grant or award Director acquired 15,294 shares (grant or award)
  4. 4 Grant or award Director acquired 15,294 shares (grant or award)
  5. 8-K Event Executive or director change · Shareholder vote results
  6. 4 Grant or award Director acquired 1,262 shares (grant or award)
  7. 4 Grant or award Director acquired 631 shares (grant or award)
  8. 4 Grant or award Director acquired 631 shares (grant or award)
  9. 4 Grant or award Director acquired 1,122 shares (grant or award)
  10. 4 Grant or award Director acquired 1,262 shares (grant or award)
  11. 4 Open-market sale Director sold 11,180 shares at $8.97 ($100,285)
  12. 144 Insider Sale of Securities
  13. 4 Planned sale Chief Legal Officer sold 62,500 shares at $9.54 ($596,250)
  14. 144 Insider Sale of Securities
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. 8-K Event Regulation FD disclosure
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. ARS Other Annual Report to Security Holders

Page 2 of 99 · 1,967 filings